Injured by Vioxx? Lawsuit and Litigation Information from Leading Attorneys
On September 30, 2004, Merck & Co. issued a worldwide recall of the blockbuster arthritis drug Vioxx from the market because of data from a clinical trial that found an increased risk of heart attacks and strokes among patients.
Vioxx has also been linked to Stevens Johnson Syndrome and Toxic Epidermal Necrolysis, which are severe life-threatening skin reactions.
Update: Schmidt & Clark is no longer accepting Vioxx cases.
What is Vioxx?
Vioxx is in a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). Vioxx works by reducing substances in the body that cause inflammation, pain, and fever. Vioxx is used to reduce pain, inflammation, and stiffness caused by osteoarthritis and adult rheumatoid arthritis. Vioxx is also used to treat painful menstruation.
Vioxx Side Effects
As with all pharmaceuticals, Vioxx comes with its list of side effects. In fact, the side effects that have been linked to Vioxx include, heart attacks, strokes, Stevens Johnson Syndrome, and Toxic Epidermal Necrolysis
Vioxx Side Effects & Lawsuit News (National)
| Fosamax Now Linked to Cancer of the Esophagus - eMaxHealth.com The FDA has reported a link between osteoporosis drugs and cancer of the esophagus. The findings are published January 1 in the New England Journal of Medicine. Eight fatal cases of cancer of the esophagus occurred out of twenty-three reported ... Will Fosamax be Vioxx all over again? - OpEdNews.com 1999 was a good year for Merck. In its 64 page annual report it predicted arthritis medicine Vioxx--Our Biggest, Fastest and Best Launch Ever!--would prevent Alzheimer's disease and colon cancer. It announced it was seeking approval to market asthma ... Specialty Medicines Led Rebound in U.S. Drug Approvals in 2008 - Bloomberg Jan. 5 (Bloomberg) -- Medicines for rare disorders and diagnosing diseases contributed to a jump in U.S. drug approvals last year from a quarter-century low in 2007. The Food and Drug Administration cleared 25 novel treatments in 2008, up from 19 the ... Anapol Schwartz Enhances Mass Tort Practice with New Attorney, Office ... - Earthtimes PHILADELPHIA - (Business Wire) Anapol, Schwartz, Weiss, Cohan, Feldman & Smalley, P.C., announced Barry Hill has joined the law firm as its resident partner in West Virginia , working from the firm?s new office in Wheeling, W.Va. Hill adds his more ... Pricing, regulation squeezed drug industry in 2008 - WTOP Radio TRENTON, N.J. (AP) - Stricter regulation, a dearth of new blockbuster drugs, increased pressure to lower prices and more intense generic competition hammered the pharmaceutical industry in 2008, but its stocks still weathered the market collapse ... A big dose of change prescribed for FDA - Philadelphia Inquirer President-elect Barack Obama is prowling for a new head for the U.S. Food and Drug Administration, which, in the eyes of some outraged Americans, is like hunting for someone to put tainted toothpaste back in its tube. In the last several years, the ... Price and regulatory pressures squeezed drug industry in 2008 ... - Newsday TRENTON, N.J. (AP) ? Stricter regulation, a dearth of new blockbuster drugs, increased pressure to lower prices and more intense generic competition hammered the pharmaceutical industry in 2008, but its stocks still weathered the market collapse ... Martha Rosenberg: New Year's Resolutions for Big Pharma - Buzzflash.com It was another year of fighting black boxes, sweet talking juries, and burying incriminating clinical data for Big Pharma. But before its reputation is completely gone (How many pharmaceutical salesmen does it take to change a light bulb? It doesn't ... Drug companies voluntarily cut swag to doctors - Seattle Times To Lehman Brothers, Linens 'n Things and the blank VHS tape, add another U.S. institution that expired in 2008: drug-company trinkets. Starting Thursday, the pharmaceutical industry has agreed to a voluntary moratorium on the kind of branded goodies ... Patient data could show medicines danger - Tasmanian Examiner THE national health safety agency is pressing the Federal Government to cross-check the huge bank of information held in the Medicare and pharmaceutical records of patients to curb thousands of avoidable illnesses and deaths caused every year by ... |
